ReviewTherapeutic advances in medical oncology2020

Resistance to immune checkpoint inhibitors in non-small cell lung cancer: biomarkers and therapeutic strategies.

Robert J Walsh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.